EP3139934A4 - Immunocompatible chorionic membrane products - Google Patents

Immunocompatible chorionic membrane products Download PDF

Info

Publication number
EP3139934A4
EP3139934A4 EP14891208.2A EP14891208A EP3139934A4 EP 3139934 A4 EP3139934 A4 EP 3139934A4 EP 14891208 A EP14891208 A EP 14891208A EP 3139934 A4 EP3139934 A4 EP 3139934A4
Authority
EP
European Patent Office
Prior art keywords
chorionic membrane
membrane products
immunocompatible chorionic
immunocompatible
products
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP14891208.2A
Other languages
German (de)
French (fr)
Other versions
EP3139934A1 (en
Inventor
Samson Tom
Alla Danilkovitch
Dana Yoo
Timothy Jansen
Jin-Qiang Kuang
Jennifer Michelle Marconi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Osiris Therapeutics Inc
Original Assignee
Osiris Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Osiris Therapeutics Inc filed Critical Osiris Therapeutics Inc
Publication of EP3139934A1 publication Critical patent/EP3139934A1/en
Publication of EP3139934A4 publication Critical patent/EP3139934A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A61K38/1866—Vascular endothelial growth factor [VEGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/40—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof, e.g. plant or animal extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Reproductive Health (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Vascular Medicine (AREA)
  • Neurology (AREA)
  • Botany (AREA)
  • Materials Engineering (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Toxicology (AREA)
  • Surgery (AREA)
  • Pain & Pain Management (AREA)
EP14891208.2A 2014-05-07 2014-05-07 Immunocompatible chorionic membrane products Withdrawn EP3139934A4 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2014/037204 WO2015171143A1 (en) 2014-05-07 2014-05-07 Immunocompatible chorionic membrane products

Publications (2)

Publication Number Publication Date
EP3139934A1 EP3139934A1 (en) 2017-03-15
EP3139934A4 true EP3139934A4 (en) 2017-11-15

Family

ID=54392805

Family Applications (1)

Application Number Title Priority Date Filing Date
EP14891208.2A Withdrawn EP3139934A4 (en) 2014-05-07 2014-05-07 Immunocompatible chorionic membrane products

Country Status (7)

Country Link
EP (1) EP3139934A4 (en)
JP (1) JP2017514507A (en)
KR (1) KR20160149292A (en)
AU (1) AU2014393403A1 (en)
CA (1) CA2948129A1 (en)
SG (1) SG11201609253PA (en)
WO (1) WO2015171143A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110256202A1 (en) 2010-02-18 2011-10-20 Samson Tom Immunocompatible amniotic membrane products
KR20170002572A (en) * 2014-05-07 2017-01-06 오시리스 쎄라퓨틱스, 인크. Immunocompatible amniotic membrane products
US20160095307A1 (en) * 2014-10-07 2016-04-07 NuTech Medical, Inc. Method and composition for hypothermic storage of placental tissue
CA3032160C (en) 2016-08-24 2024-05-28 Arthrex, Inc. Tissue hybrid for use in repairing, reconstructing or regenerating musculoskeletal degenerative processes or injuries
CN108721606A (en) * 2018-06-08 2018-11-02 广东唯泰生物科技有限公司 A kind of striae of pregnancy reparation product and preparation method thereof based on stem cell factor
US11511017B2 (en) 2019-03-12 2022-11-29 Arthrex, Inc. Ligament reconstruction
CA3179245A1 (en) * 2020-05-26 2021-12-02 Jon G. Hargis Modified porcine scaffolds and methods of preparation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2335634A1 (en) * 2000-02-11 2011-06-22 The General Hospital Corporation Photochemical tissue bonding
US20110256202A1 (en) * 2010-02-18 2011-10-20 Samson Tom Immunocompatible amniotic membrane products
US8632512B2 (en) * 2010-04-09 2014-01-21 Kci Licensing, Inc. Apparatuses, methods, and compositions for the treatment and prophylaxis of chronic wounds
KR20170002572A (en) * 2014-05-07 2017-01-06 오시리스 쎄라퓨틱스, 인크. Immunocompatible amniotic membrane products

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
MASOUMEH JORJANI: "properties of the amniotic membrane for potential use in tissue engineering", EUROPEAN CELLS AND MATERIALS, vol. 15, 1 January 2008 (2008-01-01) - 1 January 2008 (2008-01-01), pages 88 - 99, XP055412685, Retrieved from the Internet <URL:http://discovery.ucl.ac.uk/315080/1/v015a07.pdf> [retrieved on 20171004] *
See also references of WO2015171143A1 *
THOMAS J KOOB ET AL: "Biological properties of dehydrated human amnion/chorion composite graft: implications for chronic wound healing", INTERNATIONAL WOUND JOURNAL, vol. 10, no. 5, 1 August 2013 (2013-08-01), UK, pages 493 - 500, XP055259480, ISSN: 1742-4801, DOI: 10.1111/iwj.12140 *

Also Published As

Publication number Publication date
EP3139934A1 (en) 2017-03-15
WO2015171143A1 (en) 2015-11-12
JP2017514507A (en) 2017-06-08
KR20160149292A (en) 2016-12-27
AU2014393403A1 (en) 2016-11-24
CA2948129A1 (en) 2015-11-12
SG11201609253PA (en) 2016-12-29

Similar Documents

Publication Publication Date Title
EP3219488A4 (en) Decorated sheet
EP3095034A4 (en) Cybersecurity system
EP3373776A4 (en) Egg poacher
EP3171299A4 (en) Multi-smartcard
EP3161520A4 (en) Compressive scanning lidar
EP3129108A4 (en) Hoverboard
EP3204975A4 (en) Sofc-conduction
EP3205519A4 (en) Coupler
EP3194153A4 (en) Dunnage system
EP3219589A4 (en) Structural member
EP3139934A4 (en) Immunocompatible chorionic membrane products
EP3235493A4 (en) Preparation
EP3228352A4 (en) Electro-stimulator
EP3139936A4 (en) Immunocompatible amniotic membrane products
EP3094588A4 (en) Clasp-and-lug system
EP3238557A4 (en) Babygrow
EP3166949A4 (en) Thienothiophene-isoindigo
EP3118980A4 (en) Poly-generation system
EP3199528A4 (en) Abscinazole
AU2014905121A0 (en) Mould
EP3110412A4 (en) 4-benzylsulfonyl-2-butenenitrile
AU2014905278A0 (en) Membrane
AU2014905171A0 (en) GroundControl
AU2014904776A0 (en) Weldoze
AU2014904667A0 (en) Barrowmate

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20161118

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20171013

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 35/50 20150101AFI20171009BHEP

17Q First examination report despatched

Effective date: 20180613

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20190103